Skip to main content
. 2011 Aug 31;27(4):202–210. doi: 10.3393/jksc.2011.27.4.202

Fig. 2.

Fig. 2

Kaplan-Meier survival based on serum carcinoembryonic antigen (CEA) levels. (A) Patients with CEA ≤ 100 ng/mL had improved overall survival compared with those with CEA > 100 ng/mL (41.8 vs. 15.5 mo; P = 0.013). (B) Patients with CEA ≤ 100 ng/mL had improved progression-free survival compared with those with CEA > 100 ng/mL (21.6 vs. 6.3 mo; P = 0.006).